Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab

被引：0
|
作者：
Ewa Robak
Dorota Jesionek-Kupnicka
Piotr Stelmach
Piotr Kupnicki
Magdalena Szataniak
Tadeusz Robak
机构：
[1] Medical University of Lodz,Department of Dermatology
[2] Medical University of Lodz,Department of Pathology
[3] Copernicus Memorial Hospital,Department of Radiology and Diagnostic Imaging
[4] Medical University of Lodz,Department of Hematology
[5] Medical University of Lodz,undefined
来源：
Annals of Hematology | 2022年 / 101卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1387 / 1392
页数：5
相关论文
共 50 条
  • [1] Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab
    Robak, Ewa
    Jesionek-Kupnicka, Dorota
    Stelmach, Piotr
    Kupnicki, Piotr
    Szataniak, Magdalena
    Robak, Tadeusz
    ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1387 - 1392
  • [2] Venetoclax-Rituximab in Chronic Lymphocytic Leukemia
    Copur, Mehmet S.
    Gauchan, Dron
    Crockett, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22): : 2142 - +
  • [3] The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia
    Vitale, Candida
    Ferrajoli, Alessandra
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (08) : 885 - 894
  • [4] Venetoclax-Rituximab in Chronic Lymphocytic Leukemia REPLY
    Seymour, John F.
    Mobasher, Mehrdad
    Kater, Arnon P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22): : 2143 - +
  • [5] Venetoclax for the treatment of chronic lymphocytic leukemia
    Gentile, Massimo
    Petrungaro, Annamaria
    Uccello, Giuseppina
    Vigna, Ernesto
    Recchia, Anna Grazia
    Caruso, Nadia
    Bossio, Sabrina
    De Stefano, Laura
    Palummo, Angela
    Storino, Francesca
    Martino, Massimo
    Morabito, Fortunato
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1307 - 1316
  • [6] Venetoclax in the treatment of chronic lymphocytic leukemia
    Korycka-Wolowiec, Anna
    Wolowiec, Dariusz
    Kubiak-Mlonka, Aleksandra
    Robak, Tadeusz
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (05) : 353 - 366
  • [7] Venetoclax for the Treatment of Chronic Lymphocytic Leukemia
    Herbert Eradat
    Current Hematologic Malignancy Reports, 2019, 14 : 469 - 476
  • [8] Venetoclax for the Treatment of Chronic Lymphocytic Leukemia
    Eradat, Herbert
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (05) : 469 - 476
  • [9] Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic Leukemia
    Jackson, Ross A.
    Smith, Victoria M.
    Jayne, Sandrine
    Drewes, Cosima
    Bens, Susanne
    Siebert, Reiner
    Dyer, Martin J. S.
    Walter, Harriet S.
    HEMASPHERE, 2022, 6 (08):
  • [10] Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Seymour, J. F.
    Kipps, T. J.
    Eichhorst, B.
    Hillmen, P.
    D'Rozario, J.
    Assouline, S.
    Owen, C.
    Gerecitano, J.
    Robak, T.
    De la Serna, J.
    Jaeger, U.
    Cartron, G.
    Montillo, M.
    Humerickhouse, R.
    Punnoose, E. A.
    Li, Y.
    Boyer, M.
    Humphrey, K.
    Mobasher, M.
    Kater, A. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12): : 1107 - 1120
12345